Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Immunological Evaluation of Pediatric Patients with Polyautoimmunity

Author(s): Fatemeh Sadat Mahdavi, Marzieh Tavakol*, Fatemeh Aghamahdi*, Homa Sadri*, Zahra Chavoshzadeh, Mahnaz Jamee, Shahab Noorian, Mohammad Reza Alaei, Pooya Ashkevari, Juan-Manuel Anaya, Hassan Abolhassani, Hans D Ochs and Gholamreza Azizi*

Volume 24, Issue 7, 2024

Published on: 10 October, 2023

Page: [798 - 807] Pages: 10

DOI: 10.2174/1871530323666230912124951

Price: $65

Abstract

Background: Autoimmunity can be the first or predominant manifestation in patients with primary immunodeficiency disorder, also known as inborn errors of immunity (IEI). This study aims to evaluate the immune status of pediatric patients with polyautoimmunity to identify those with underlying immune defects.

Methods: In this cross-sectional study, pediatric patients with polyautoimmunity including at least one confirmed autoimmune endocrine disease were enrolled. Demographic and clinical data were collected using a questionnaire based on medical records and direct family interviews. For each patient, a basic immunologic evaluation was performed. The clinical diagnosis was established according to the criteria of the European Society for Immunodeficiencies (ESID). Based on the presence or absence of a history of severe and/or recurrent infections, patients were divided into two groups for comparison.

Results: Thirty-nine patients, 18 males (46.2%) and 21 females (53.8%), were included. Fourteen patients (35.9%) had consanguineous parents. Fifteen patients (38.5%) had a history of severe and/or recurrent infections. The median (interquartile range: IQR) age of our patients at the time of evaluation was 11.1 (9-16) years. The median (IQR) age at the onset of infections and autoimmunities were 3 (1-10.8) and 5 (2.6-8) years, respectively. The most common infectious complications reported were pneumonia and candidiasis, each in 12.8% of the patients. The most prevalent autoimmune disorders were type 1 diabetes (74.3%) and autoimmune thyroiditis (58.9%). IEI was diagnosed in six patients (15.38%), five of which were from the group with severe or recurrent infections: three with selective IgA deficiency, two with common variable immunodeficiency (CVID), and one with immune dysregulation, polyendocrinopathy, enteropathy, Xlinked (IPEX), but without a history of infections.

Conclusion: The occurrence of early onset polyautoimmunity in association with severe and/or recurrent infections or in patients with a positive family history should be a warning sign for physicians to initiate an evaluation for possible immunodeficiency disorders to prevent complications through early treatment.

Keywords: Polyautoimmunity, recurrent infections, inborn errors of immunity, autoimmune endocrinopathy, pediatric patients, autoimmunity.

« Previous Next »
Graphical Abstract

[1]
Anaya, J.M. The autoimmune tautology. Arthritis Res. Ther., 2010, 12(6), 147.
[http://dx.doi.org/10.1186/ar3175] [PMID: 21092150]
[2]
Hode, A.; Dédjan, H. Autoimmune thyroiditis - track towards autoimmune polyendocrinopathy type III. Archive of Clinical Cases, 2019, 6(4), 109-111.
[http://dx.doi.org/10.22551/2019.25.0604.10163] [PMID: 34754918]
[3]
Husebye, E.S.; Anderson, M.S. Kämpe, O. Autoimmune polyendocrine syndromes. N. Engl. J. Med., 2018, 378(12), 1132-1141.
[http://dx.doi.org/10.1056/NEJMra1713301] [PMID: 29562162]
[4]
Ruggeri, R.M.; Giuffrida, G. Campennì, A. Autoimmune endocrine diseases. Minerva Endocrinol., 2018, 43(3), 305-322.
[PMID: 28990742]
[5]
Frommer, L.; Kahaly, G.J. Autoimmune polyendocrinopathy. J. Clin. Endocrinol. Metab., 2019, 104(10), 4769-4782.
[http://dx.doi.org/10.1210/jc.2019-00602] [PMID: 31127843]
[6]
Thalhammer, J.; Kindle, G.; Nieters, A.; Rusch, S. Seppänen, MR; Fischer, A. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. J. Allergy Clin. Immunol., 2021, 148(5), 1332-1341.
[7]
Costagliola, G.; Peroni, D.G.; Consolini, R. Beyond infections: New warning signs for inborn errors of immunity in children. Front Pediatr., 2022, 10, 855445.
[http://dx.doi.org/10.3389/fped.2022.855445] [PMID: 35757131]
[8]
Walter, J.E.; Ayala, I.A.; Milojevic, D. Autoimmunity as a continuum in primary immunodeficiency. Curr. Opin. Pediatr., 2019, 31(6), 851-862.
[http://dx.doi.org/10.1097/MOP.0000000000000833] [PMID: 31693597]
[9]
Jamee, M.; Alaei, M.R.; Mesdaghi, M.; Noorian, S.; Moosavian, M.; Dolatshahi, E.; Kojidi, H.; Chavoshzadeh, Z.; Fallahi, M.; Parviz, S.; Aghamahdi, F.; Azizi, G. The prevalence of selective and partial immunoglobulin a deficiency in patients with autoimmune polyendocrinopathy. Immunol. Invest., 2022, 51(4), 778-786.
[http://dx.doi.org/10.1080/08820139.2021.1872615] [PMID: 33432864]
[10]
Azizi, G.; Tavakol, M.; Yazdani, R.; Delavari, S.; Moeini Shad, T.; Rasouli, S.E.; Jamee, M.; Pashangzadeh, S.; Kalantari, A.; Shariat, M.; Shafiei, A.; Mohammadi, J.; Hassanpour, G.; Chavoshzadeh, Z.; Mahdaviani, S.A.; Momen, T.; Behniafard, N.; Nabavi, M.; Bemanian, M.H.; Arshi, S.; Molatefi, R.; Sherkat, R.; Shirkani, A.; Alyasin, S.; Jabbari-Azad, F.; Ghaffari, J.; Mesdaghi, M.; Ahanchian, H.; Khoshkhui, M.; Eslamian, M.H.; Cheraghi, T.; Dabbaghzadeh, A.; Nasiri Kalmarzi, R.; Esmaeilzadeh, H.; Tafaroji, J.; Khalili, A.; Sadeghi-Shabestari, M.; Darougar, S.; Moghtaderi, M.; Ahmadiafshar, A.; Shakerian, B.; Heidarzadeh, M.; Ghalebaghi, B.; Fathi, S.M.; Darabi, B.; Fallahpour, M.; Mohsenzadeh, A.; Ebrahimi, S.; Sharafian, S.; Vosughimotlagh, A.; Tafakoridelbari, M.; Rahimi Haji-Abadi, M.; Ashournia, P.; Razaghian, A.; Rezaei, A.; Salami, F.; Shirmast, P.; Bazargan, N.; Mamishi, S.; Khazaei, H.A.; Negahdari, B.; Shokri, S.; Nabavizadeh, S.H.; Bazregari, S.; Ghasemi, R.; Bayat, S.; Eshaghi, H.; Rezaei, N.; Abolhassani, H.; Aghamohammadi, A. Autoimmune manifestations among 461 patients with monogenic inborn errors of immunity. Pediatr. Allergy Immunol., 2021, 32(6), 1335-1348.
[http://dx.doi.org/10.1111/pai.13510] [PMID: 33774840]
[11]
Azizi, G.; Tavakol, M.; Rafiemanesh, H.; Kiaee, F.; Yazdani, R.; Heydari, A.; Abouhamzeh, K.; Anvari, P.; Mohammadikhajehdehi, S.; Sharifia, L.; Bagheri, Y.; Mohammadi, H.; Abolhassani, H.; Aghamohammadi, A. Autoimmunity in a cohort of 471 patients with primary antibody deficiencies. Expert Rev. Clin. Immunol., 2017, 13(11), 1099-1106.
[http://dx.doi.org/10.1080/1744666X.2017.1384312] [PMID: 29019451]
[12]
Costagliola, G.; Cappelli, S.; Consolini, R. Autoimmunity in primary immunodeficiency disorders: An updated review on pathogenic and clinical implications. J. Clin. Med., 2021, 10(20), 4729.
[http://dx.doi.org/10.3390/jcm10204729] [PMID: 34682853]
[13]
Tangye, S.G.; Al-Herz, W.; Bousfiha, A.; Cunningham-Rundles, C.; Franco, J.L.; Holland, S.M.; Klein, C.; Morio, T.; Oksenhendler, E.; Picard, C.; Puel, A.; Puck, J. Seppänen, M.R.J.; Somech, R.; Su, H.C.; Sullivan, K.E.; Torgerson, T.R.; Meyts, I. Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee. J. Clin. Immunol., 2022, 42(7), 1473-1507.
[http://dx.doi.org/10.1007/s10875-022-01289-3] [PMID: 35748970]
[14]
Odnoletkova, I.; Kindle, G.; Quinti, I.; Grimbacher, B.; Knerr, V.; Gathmann, B.; Ehl, S.; Mahlaoui, N.; Van Wilder, P.; Bogaerts, K.; de Vries, E. The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data. Orphanet J. Rare Dis., 2018, 13(1), 201.
[http://dx.doi.org/10.1186/s13023-018-0941-0] [PMID: 30419968]
[15]
Jacob, C.M.A.; Pastorino, A.C.; Fahl, K.; Carneiro-Sampaio, M.; Monteiro, R.C. Autoimmunity in IgA deficiency: Revisiting the role of IgA as a silent housekeeper. J. Clin. Immunol., 2008, 28(S1)(Suppl. 1), 56-61.
[http://dx.doi.org/10.1007/s10875-007-9163-2] [PMID: 18202833]
[16]
Ludvigsson, J.F.; Neovius, M.; Hammarströِm, L. Association between IgA deficiency & other autoimmune conditions: A population-based matched cohort study. J. Clin. Immunol., 2014, 34(4), 444-451.
[http://dx.doi.org/10.1007/s10875-014-0009-4] [PMID: 24584841]
[17]
Yazdani, R.; Azizi, G.; Abolhassani, H.; Aghamohammadi, A. Selective IgA deficiency: Epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management. Scand. J. Immunol., 2017, 85(1), 3-12.
[http://dx.doi.org/10.1111/sji.12499] [PMID: 27763681]
[18]
Shoenfeld, Y; Cervera, R; Gershwin, ME Diagnostic criteria in autoimmune diseases., 2010.
[19]
Sogkas, G.; Atschekzei, F.; Adriawan, I.R.; Dubrowinskaja, N.; Witte, T.; Schmidt, R.E. Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity. Cell. Mol. Immunol., 2021, 18(5), 1122-1140.
[http://dx.doi.org/10.1038/s41423-020-00626-z] [PMID: 33795850]
[20]
Padron, G.T.; Hernandez-Trujillo, V.P. Autoimmunity in primary immunodeficiencies (PID). Clin. Rev. Allergy Immunol., 2022, 65(1), 1-18.
[http://dx.doi.org/10.1007/s12016-022-08942-0] [PMID: 35648371]
[21]
Dittmar, M.; Kahaly, G.J. Polyglandular autoimmune syndromes: Immunogenetics and long-term follow-up. J. Clin. Endocrinol. Metab., 2003, 88(7), 2983-2992.
[http://dx.doi.org/10.1210/jc.2002-021845] [PMID: 12843130]
[22]
Moaiery, H. Prevalence of goiter and thyroid disorders in diabetic children. Teh. Uni. Med. J. T. Pub., 2001, 59(3), 5-7.
[23]
Bahrami, A. Autoimmune thyroid disorders in patients with type 1 diabetes mellitus; results of long term follow up of a large cohort of patients in endocrine and diabetes clinics of tabriz university of medical sciences. Med. J. Tab. Uni. Med. Sci., 2012, 34(1), 22-27.
[24]
Hoyt, K.J.; Chatila, T.A.; Notarangelo, L.D.; Hazen, M.M.; Janssen, E.; Henderson, L.A. The immunologic features of patients with early-onset and polyautoimmunity. Clin. Immunol., 2020, 211, 108326.
[http://dx.doi.org/10.1016/j.clim.2019.108326] [PMID: 31838215]
[25]
Sarmiento, E.; Mora, R. Rodríguez-Mahou, M.; Rodríguez-Molina, J.; Fernández-Cruz, E.; Carbone, J. (Autoimmune disease in primary antibody deficiencies). Allergol. Immunopathol., 2005, 33(2), 69-73.
[http://dx.doi.org/10.1157/13072916] [PMID: 15808112]
[26]
Azizi, G.; Ahmadi, M.; Abolhassani, H.; Yazdani, R.; Mohammadi, H.; Mirshafiey, A.; Rezaei, N.; Aghamohammadi, A. Autoimmunity in primary antibody deficiencies. Int. Arch. Allergy Immunol., 2016, 171(3-4), 180-193.
[http://dx.doi.org/10.1159/000453263] [PMID: 28013299]
[27]
Moschese, V.; Chini, L.; Graziani, S.; Sgrulletti, M.; Gallo, V.; Di Matteo, G.; Ferrari, S.; Di Cesare, S.; Cirillo, E.; Pession, A.; Pignata, C.; Specchia, F. Follow-up and outcome of symptomatic partial or absolute IgA deficiency in children. Eur. J. Pediatr., 2019, 178(1), 51-60.
[http://dx.doi.org/10.1007/s00431-018-3248-1] [PMID: 30269248]
[28]
Barsalou, J.; Saint-Cyr, C.; Drouin, E.; Le Deist, F.; Haddad, E. High prevalence of primary immune deficiencies in children with autoimmune disorders. Clin. Exp. Rheumatol., 2011, 29(1), 125-130.
[PMID: 21345299]
[29]
Salzer, U.; Warnatz, K.; Peter, H. Common variable immunodeficiency - an update. Arthritis Res. Ther., 2012, 14(5), 223.
[http://dx.doi.org/10.1186/ar4032] [PMID: 23043756]
[30]
Gereige, J.D.; Maglione, P.J. Current understanding and recent developments in common variable immunodeficiency associated autoimmunity. Front. Immunol., 2019, 10, 2753.
[http://dx.doi.org/10.3389/fimmu.2019.02753] [PMID: 31921101]
[31]
Asgardoon, M.H.; Azizi, G.; Yazdani, R.; Sohani, M.; Pashangzadeh, S.; Kalantari, A.; Shariat, M.; Shafiei, A.; Salami, F.; Jamee, M.; Rasouli, S.E.; Mohammadi, J.; Hassanpour, G.; Tavakol, M.; Chavoshzadeh, Z.; Mahdaviani, S.A.; Momen, T.; Behniafard, N.; Nabavi, M.; Bemanian, M.H.; Arshi, S.; Molatefi, R.; Sherkat, R.; Shirkani, A.; Alyasin, S.; Jabbari-Azad, F.; Ghaffari, J.; Mesdaghi, M.; Ahanchian, H.; Khoshkhui, M.; Eslamian, M.H.; Cheraghi, T.; Dabbaghzadeh, A.; Nasiri Kalmarzi, R.; Esmaeilzadeh, H.; Tafaroji, J.; Khalili, A.; Sadeghi-Shabestari, M.; Darougar, S.; Moghtaderi, M.; Ahmadiafshar, A.; Shakerian, B.; Heidarzadeh, M.; Ghalebaghi, B.; Fathi, S.M.; Darabi, B.; Fallahpour, M.; Mohsenzadeh, A.; Ebrahimi, S.; Sharafian, S.; Vosughimotlagh, A.; Tafakoridelbari, M.; Rahimi Haji-Abadi, M.; Ashournia, P.; Razaghian, A.; Rezaei, A.; Delavari, S.; Shirmast, P.; Babaha, F.; Samavat, A.; Mamishi, S.; Khazaei, H.A.; Negahdari, B.; Rezaei, N.; Abolhassani, H.; Aghamohammadi, A. Monogenic primary immunodeficiency disorder associated with common variable immunodeficiency and autoimmunity. Int. Arch. Allergy Immunol., 2020, 181(9), 706-714.
[http://dx.doi.org/10.1159/000508817] [PMID: 32615565]
[32]
Bahceci, M.; Tuzcu, A.; Pasa, S.; Ayyildiz, O.; Tuzcu, S. Polyglandular autoimmune syndrome type III accompanied by common variable immunodeficiency. Gynecol. Endocrinol., 2004, 19(1), 47-50.
[http://dx.doi.org/10.1080/09513590410001725279] [PMID: 15625773]
[33]
Topaloglu, A.K.; Yuksel, B.; Yilmaz, M.; Mungan, N.O.; Guneser, S.; Ozer, G. Coexistence of common variable immunodeficiency and autoimmune polyglandular syndrome type 2. J. Pediatr. Endocrinol. Metab., 2001, 14(5), 565-566.
[http://dx.doi.org/10.1515/JPEM.2001.14.5.565] [PMID: 11393580]
[34]
Shikdar, Y.A.; Almazrooa, A.; Samargandy, S. SAT-071 autoimmune polyglandular syndrome type 1 with common variable immunodeficiency. J. Endocr. Soc., 2020, 4(1), SAT-071.
[http://dx.doi.org/10.1210/jendso/bvaa046.152]
[35]
Jamee, M.; Zaki-Dizaji, M.; Lo, B.; Abolhassani, H.; Aghamahdi, F.; Mosavian, M. Clinical, immunological, and genetic features in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-like syndrome. J. Allergy Clini. Immunol.: In Practice, 2020, 8(8), 2747-2760.
[36]
Gambineri, E.; Ciullini Mannurita, S.; Hagin, D.; Vignoli, M.; Anover-Sombke, S.; DeBoer, S.; Segundo, G.R.S.; Allenspach, E.J.; Favre, C.; Ochs, H.D.; Torgerson, T.R. Clinical, immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Front. Immunol., 2018, 9, 2411.
[http://dx.doi.org/10.3389/fimmu.2018.02411] [PMID: 30443250]

Rights & Permissions Print Cite
Article Metrics
17
2
© 2024 Bentham Science Publishers | Privacy Policy